1McCabe, MP, Sharlip, ID, Lewis, R, Atalla, E, Balon, R, Fisher, AD, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016; 13: 153–67.
2Montejo, AL, Montejo, L, Baldwin, DS. The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry 2018; 17: 3–11.
3Kaufman, KR, Coluccio, M, Sivaraaman, K, Campeas, M. Lamotrigine-induced sexual dysfunction and noncompliance: case analysis with literature review. BJPsych Open 2017; 3: 249–53.
4Kaufman, KR, Wong, S, Sivaraaman, K, Anim, C, Delatte, D. Epilepsy and AED-induced decreased libido – the unasked psychosocial comorbidity. Epilepsy Behav 2015; 52: 236–8.
5Mitchell, AJ, Selmes, T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatri Treat 2007; 13: 336–46.
6La Torre, A, Giupponi, G, Duffy, D, Conca, A. Sexual dysfunction related to psychotropic drugs: a critical review – part I: antidepressants. Pharmacopsychiatry 2013; 46: 191–9.
7La Torre, A, Conca, A, Duffy, D, Giupponi, G, Pompili, M, Grözinger, M. Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics. Pharmacopsychiatry 2013; 46: 201–8.
8La Torre, A, Giupponi, G, Duffy, DM, Pompili, M, Grözinger, M, Kapfhammer, HP, et al. Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs. Pharmacopsychiatry 2014; 47: 1–6.
9Fossey, MD, Hamner, MB. Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety 1994–1995; 1: 233–6.
10Shen, WW, Sata, LS. Inhibited female orgasm resulting from psychotropic drugs. A five-year, updated, clinical review. J Reprod Med 1990; 35: 11–4.
11Lydiard, RB, Howell, EF, Laraia, MT, Ballenger, JC. Sexual side effects of alprazolam. Am J Psychiatry 1987; 144: 254–5.
12O'Sullivan, GH, Noshirvani, H, Başoğlu, M, Marks, IM, Swinson, R, Kuch, K, et al. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder. Br J Psychiatry 1994; 165: 79–86.
13Márquez, M, Arenoso, H, Caruso, N. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders. Actas Esp Psiquiatr 2011; 39: 88–94.
14McGahuey, CA, Gelenberg, AJ, Laukes, CA, Moreno, FA, Delgado, PL, McKnight, KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26: 25–40.
15Naranjo, CA, Shear, NH, Lanctôt, KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 1992; 32: 897–904.
16Kendurkar, A, Kaur, B. Major depressive disorder, obsessive–compulsive disorder, and generalized anxiety disorder: do the sexual dysfunctions differ? Prim Care Companion J Clin Psychiatry 2008; 10: 299–305.
17Bodinger, L, Hermesh, H, Aizenberg, D, Valevski, A, Marom, S, Shiloh, R, et al. Sexual function and behavior in social phobia. J Clin Psychiatry 2002; 63: 874–9.
18Aksoy, UM, Aksoy, SG, Maner, F, Gokalp, P, Yanik, M. Sexual dysfunction in obsessive compulsive disorder and panic disorder. Psychiatr Danub 2012; 24: 381–5.
19Blumentals, WA, Gomez-Caminero, A, Brown, RR, Vannappagari, V, Russo, LJ. A case control study of erectile dysfunction among men with panic disorder. Int J Impot Res 2004; 16: 299–302.
20Bijlenga, D, Vroege, JA, Stammen, AJM, Breuk, M, Boonstra, AM, van der Rhee, K, et al. Prevalence of sexual dysfunctions and other sexual disorders in adults with attention-deficit/hyperactivity disorder compared to the general population. Atten Defic Hyperact Disord. 2018; 10: 87–96.
21Iovino, P, Pascariello, A, Limongelli, P, Tremolaterra, F, Consalvo, D, Sabbatini, F, et al. The prevalence of sexual behavior disorders in patients with treated and untreated gastroesophageal reflux disease. Surg Endosc 2007; 21: 1104–10.
22Katz, A. Obesity and sexual dysfunction: making the connection. Am J Nurs 2017; 117: 45–50.
23Serretti, A, Chiesa, A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009; 29: 259–66.
24Strohmaier, J, Wüst, S, Uher, R, Henigsberg, N, Mors, O, Hauser, J, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. World J Biol Psychiatry 2011; 12: 528–38.
25Kaufman, KR, Struck, PJ. Gabapentin-induced sexual dysfunction. Epilepsy Behav 2011; 21: 324–6.
26Wright, CE. Clinical pharmacokinetics of alprazolam extended release: a summary. Curr Therap Res 1995; 56: 947–56.
27Glue, P, Fang, A, Gandelman, K, Klee, B. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers. Am J Ther 2006; 13: 418–22.
28Hall, J, Naranjo, CA, Sproule, BA, Herrmann, N. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine. J Clin Psychopharmacol 2003; 23: 349–57.
29Goodchild, CS. GABA receptors and benzodiazepines. Br J Anaesth 1993; 71: 127–33.
30Griffin, CE 3rd, Kaye, AM, Bueno, FR, Kaye, AD. Benzodiazepine pharmacology and central nervous system–mediated effects. Ochsner J. 2013; 13: 214–23.
31Fernández-Guasti, A, Larsson, K, Beyer, C. GABAergic control of masculine sexual behavior. Pharmacol Biochem Behav 1986; 24: 1065–70.
32Rodríguez-Manzo, G, Canseco-Alba, A. A new role for GABAergic transmission in the control of male rat sexual behavior expression. Behav Brain Res 2017; 320: 21–9.
33Lee, TY, Pan, JT. Involvement of central GABAergic neurons in basal and diurnal changes of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion. Life Sci 2001; 68: 1965–75.
34Hollander, AB, Pastuszak, AW, Hsieh, TC, Johnson, WG, Scovell, JM, Mai, CK, et al. Cabergoline in the treatment of male orgasmic disorder – a retrospective pilot analysis. Sex Med 2016; 4: e28–33.
35Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593–602.
36Moffitt, TE, Caspi, A, Taylor, A, Kokaua, J, Milne, BJ, Polanczyk, G, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 2010; 40: 899–909.
37Moore, TJ, Mattison, DR. Adult utilization of psychiatric drugs and differences by sex, age, and race. JAMA Intern Med 2017; 177: 274–5.